Clinical Trial Update: Sitosterolemia Extension Study (0653-004)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 extension study for sitosterolemia (0653-004) sponsored by Organon and Co has completed; the snippet does not include efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hyperlipidemia
• Sitosterolemia

Snippet

Sponsor: Organon and Co | Conditions: Lipid Metabolism, Inborn Errors, Heart Disease | Phase 3 | Status: COMPLETED